CJC-1295 (No DAC) + Ipamorelin Blend
$79.75
Growth hormone secretagogue research blend · Research Use Only
Fast, Dependable Fulfillment.
Orders are processed promptly and shipped within 48 hours of purchase and successful
payment confirmation — because your research shouldn’t wait on us
Research Use Only.
This compound is supplied strictly for in vitro research purposes. It is not approved by the FDA and is not intended for human consumption, therapeutic, diagnostic, or veterinary use. By purchasing, you confirm you are a qualified researcher aged 18+.
- HPLC Verified
- COA Included
- For 21+ Only
- US Sourced
This blend combines CJC-1295 (no DAC), a 29-amino-acid growth-hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue receptor agonist — two compounds studied together for their complementary mechanisms along the GH-release pathway.
Research focus: In preclinical models, CJC-1295 is studied for amplifying GH pulse amplitude via the GHRH receptor, while Ipamorelin is studied for increasing pulse frequency via the ghrelin receptor (GHSR-1a) — notably without significantly affecting cortisol, prolactin, or ACTH, a selectivity that distinguishes it from older secretagogues. Combined, research has reported GH elevation exceeding either compound studied alone, while preserving a physiological pulsatile release pattern.
Specifications
CJC-1295 (no DAC): C₁₅₂H₂₅₂N₄₄O₄₂ · ~3,367.9 g/mol
Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ · C₃₈H₄₉N₉O₅ · ~711.87 g/mol · CAS 170851-70-4
Purity: ≥99% per component (HPLC verified)
Form: Lyophilized powder
For laboratory research use only. Not for human or veterinary use, diagnosis, treatment, or consumption. Not evaluated by the FDA.
You may also research
Related Compounds
Reviews
There are no reviews yet.